BeStock  
Stocks › Biotechnology › LTGO

Latigo Biotherapeutics LTGO

US equityMarket cap rank #3257Biotechnology
$13.00 −$0.24 (-1.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.00 0.00%
Open$13.22
Prev close$13.24
Day range$11.91 – $13.35
Volume267.2K
Market cap$861.89M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership74.5%+74.55 pts vs. prior quarter
Institutions holding31+31 vs. prior quarter
Insider trades (recent)6 buys / 0 sellsNet buying
Short interest1.42% of floatDays to cover 5.4 · as of 30 Oct 2026
Short-sale volume share23.3%5-day average of daily volume

Short-sale volume as % of daily volume

8%17%25%34%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$6.41M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$5.9MSuper−$472.2KBig−$460.7KMid−$239.0KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 59.5% of shares outstanding.

Largest holders

  • Westlake Village BioPartners19.91%
  • Foresite Capital Management, LLC13.85%
  • 5AM Venture Management, LLC11.05%
  • RA Capital Management, L.P.7.99%
  • Deep Track Capital, LP6.71%
  • Leonard Blavatnik4.82%
  • Blue Owl Credit Private Fund Advisors LLC4.75%
  • FMR4.34%

By investor type

  • VC/PE Fund59.54%
  • Mutual Fund8.97%
  • Individual/Insider6.53%
  • Hedge Fund4.84%
  • Public Company1.03%
  • Private Company0.17%

Reported short interest has risen from 0.22% to 1.42% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Charles Schwab Investment Management Mutual Fund 2026/Q3 +110,534 0.2%
Westlake Village BioPartners VC/PE Fund 2026/Q3 +13,199,669 19.9%
FMR Mutual Fund 2026/Q3 +2,878,973 4.3%
abrdn plc Mutual Fund 2026/Q3 +935,718 1.4%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +865,977 1.3%
Sanofi Public Company 2026/Q3 +672,778 1.0%
UBS Asset Management Mutual Fund 2026/Q3 +293,297 0.4%
BlackRock Mutual Fund 2026/Q3 +292,086 0.4%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +220,175 0.3%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +216,879 0.3%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +9,108 0.0%
Leonard Blavatnik Individual/Insider 2026/Q3 +3,193,565 4.8%
FMR Mutual Fund 2026/Q3 +1,018,728 1.5%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +67,364 0.1%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,074 0.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Aug 2026 Sanofi Derivative Exercise and Retained +672,778 – 672,788
9 Aug 2026 5AM Venture Management, LLC Derivative Exercise and Retained +7,325,962 – 7,325,962
9 Aug 2026 Foresite Capital Management, LLC Open Market Acquisition +140,000 $18.00 9,181,328
9 Aug 2026 Foresite Capital Management, LLC Derivative Exercise and Retained +9,041,328 – 9,181,328
9 Aug 2026 Westlake Village BioPartners Derivative Exercise and Retained +12,695,305 – 13,199,669
5 Aug 2026 James Tananbaum Independent Director Initial Statement of Beneficial +0 – 1,484,401
5 Aug 2026 Sanofi Initial Statement of Beneficial +0 – 494,800
5 Aug 2026 Andrew Schwab Initial Statement of Beneficial +0 – 1,484,401
5 Aug 2026 Timothy Walbert Independent Chairperson Initial Statement of Beneficial +0 – 329,819
5 Aug 2026 Todd Smith PresIdent, CEO & Director Other Derivative Acquisition +105,542 $18.00 105,542
5 Aug 2026 Nima Farzan Officer Initial Statement of Beneficial +0 – 2,787,966
5 Aug 2026 Sara Bonstein Independent Director Initial Statement of Beneficial +0 – 105,542
5 Aug 2026 Westlake Village BioPartners Initial Statement of Beneficial +0 – 679,620
5 Aug 2026 Neha Krishnamohan Chief Business Officer & CFO Initial Statement of Beneficial +0 – 686,026

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 941,434 1.4% 5.4
15 Oct 2026 785,880 1.2% 2.5
30 Sep 2026 832,088 1.3% 1.6
15 Sep 2026 449,962 0.7% 2.1
31 Aug 2026 308,625 0.5% 1.7
14 Aug 2026 134,468 0.2% 1.0

Discussion

No comments yet — be the first to weigh in on LTGO.

Sign in to join the discussion.

Scroll to Top